Silence Therapeutics (LON:SLN) Shares Cross Below 200 Day Moving Average of $535.00

Silence Therapeutics plc (LON:SLN)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 535 ($6.80) and traded as low as GBX 512 ($6.51). Silence Therapeutics shares last traded at GBX 535 ($6.80), with a volume of 913,528 shares trading hands.

Silence Therapeutics Stock Down 0.9 %

The company has a 50-day moving average of GBX 535 and a 200-day moving average of GBX 535. The company has a market capitalization of £480.35 million and a price-to-earnings ratio of -11.01. The company has a current ratio of 4.52, a quick ratio of 4.36 and a debt-to-equity ratio of 0.80.

Silence Therapeutics Company Profile

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated genes in the liver.